These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7682204)

  • 1. Immunomodulation of experimental allergic encephalomyelitis.
    Arnon R; Teitelbaum D
    Isr J Med Sci; 1993; 29(2-3):175-81. PubMed ID: 7682204
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)].
    Lebar R; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099
    [No Abstract]   [Full Text] [Related]  

  • 4. Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?
    Alvord EC; Shaw CM; Hruby S; Kies MW
    Ann Neurol; 1979 Dec; 6(6):461-8. PubMed ID: 93873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactive T cells in multiple sclerosis.
    Zhang J; Weiner HL; Hafler DA
    Int Rev Immunol; 1992; 9(3):183-201. PubMed ID: 1285060
    [No Abstract]   [Full Text] [Related]  

  • 6. The thymus plays a role in oral tolerance induction in experimental autoimmune encephalomyelitis.
    Song F; Gienapp IE; Shawler T; Guan Z; Whitacre CC
    Ann N Y Acad Sci; 2004 Dec; 1029():402-4. PubMed ID: 15681792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copolymer 1 from the laboratory to FDA.
    Teitelbaum D; Sela M; Arnon R
    Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental autoimmunity.
    Nussenblatt RB; Gunn HC; Ryffel B; Borel JF
    Prog Allergy; 1986; 38():159-80. PubMed ID: 3487790
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental allergic encephalomyelitis antigen (author's transl)].
    Nagai Y; Nakano K
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):794-9. PubMed ID: 4140545
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of vitamin E and thymalin on the development of experimental allergic encephalomyelitis].
    Vilkov GA; Stepanenko EM; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1987 Sep; 104(9):288-90. PubMed ID: 3663910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanticity of synthetic polynucleotides for induction of experimental allergic encephalomyelitis in guinea pigs.
    Paterson PY; Drobish DG
    J Immunol; 1974 Dec; 113(6):1942-6. PubMed ID: 4139200
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
    Kumar V; Sercarz E
    J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen.
    Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
    Eur J Immunol; 1973 May; 3(5):273-9. PubMed ID: 4128127
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Meyer AL; Benson JM; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1996 Nov; 157(9):4230-8. PubMed ID: 8892661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation and identification of antigen-specific T-cell-receptors (author's transl)].
    Bartmann P; Brendel W
    J Clin Chem Clin Biochem; 1980 Jan; 18(1):1-5. PubMed ID: 6153698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P; Garren H; Steinman L
    Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disease: immunotherapy by peptides?
    Janeway CA
    Nature; 1989 Oct; 341(6242):482-3. PubMed ID: 2477706
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunospecific drug design--prospects for treatment of autoimmune diseases.
    Arnon R; Teitelbaum D
    Ther Immunol; 1994 Jan; 1(1):65-70. PubMed ID: 7584481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity: physiologic and pernicious.
    Cohen IR
    Adv Intern Med; 1984; 29():147-65. PubMed ID: 6201052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.